Korean Drug Co., Ltd. (KOSDAQ:014570)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,950.00
-10.00 (-0.20%)
At close: Jun 18, 2025, 3:30 PM KST
-20.29%
Market Cap 54.01B
Revenue (ttm) 66.77B
Net Income (ttm) 447.34M
Shares Out 10.91M
EPS (ttm) 41.60
PE Ratio 118.98
Forward PE n/a
Dividend 160.00 (3.23%)
Ex-Dividend Date Dec 27, 2024
Volume 32,645
Average Volume 14,608
Open 4,960.00
Previous Close 4,960.00
Day's Range 4,885.00 - 4,960.00
52-Week Range 4,095.00 - 6,340.00
Beta 0.43
RSI 58.58
Earnings Date Aug 27, 2025

About Korean Drug

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 270
Stock Exchange KOSDAQ
Ticker Symbol 014570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.